Predict your next investment

Glactone Pharma company logo
HEALTHCARE | Drug Development
glactone.com

See what CB Insights has to offer

Stage

Seed | Alive

Total Raised

$850K

Last Raised

$850K | 8 yrs ago

About Glactone Pharma

Glactone Pharma is developing a drug for the treatment of castration resistant prostate cancer. Research has shown that the natural product galiellalactone can modulate a signaling protein (STAT3) that is over activated in cancer cells. The goal is to develop drugs against metastasizing cancer where galiellalactone is used as a chemical starting point to make new novel, patentable compounds.

Glactone Pharma Headquarter Location

Kullagatan 8

Helsingborg, SE-252 20,

Sweden

Latest Glactone Pharma News

Aqilion sheds portfolio company Glactone Pharma

Dec 9, 2019

Swedish life science company Aqilion says it is selling its entire stake in portfolio company Glactone… To continue reading The Pharma Letter please login ,   subscribe  or  claim a 7 day free trial subscription  and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. PLUS... you can receive the Pharma Letter headlines and news roundup email free forever Only £77 per month or £820 per year No-limits access to our site with up-to-the minute news Personalised news and email alerts Online discussion forums and Q&A section RSS news feeds that you can add to your favourite reader, or website Daily news email alert, with the breaking news stories and news roundup

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Glactone Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Glactone Pharma is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Glactone Pharma Patents

Glactone Pharma has filed 5 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Proteins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/5/2017

9/22/2020

Transcription factors, Clusters of differentiation, Proteins, Signal transduction, Immune system

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/5/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/22/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Clusters of differentiation, Proteins, Signal transduction, Immune system

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.